• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

AGA 临床实践更新:难治性幽门螺杆菌感染的管理:专家综述。

AGA Clinical Practice Update on the Management of Refractory Helicobacter pylori Infection: Expert Review.

机构信息

Gastroenterology Section, VA San Diego Healthcare System, La Jolla, California; VA Tennessee Valley Health System, Nashville, Tennessee; Division of Gastroenterology, Hepatology, and Nutrition, Vanderbilt University Medical Center, Nashville, Tennessee.

Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota.

出版信息

Gastroenterology. 2021 Apr;160(5):1831-1841. doi: 10.1053/j.gastro.2020.11.059. Epub 2021 Jan 29.

DOI:10.1053/j.gastro.2020.11.059
PMID:33524402
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8281326/
Abstract

The purpose of this CPU Expert Review is to provide clinicians with guidance on the management of Helicobacter pylori after an initial attempt at eradication therapy fails, including best practice advice on specific regimen selection, and consideration of patient and systems factors that contribute to treatment efficacy. This Expert Review is not a formal systematic review, but is based upon a review of the literature to provide practical advice. No formal rating of the strength or quality of the evidence was carried out. Accordingly, a combination of available evidence and consensus-based expert opinion were used to develop these best practice advice statements.

摘要

本 CPU 专家评论的目的是为临床医生提供初始根除治疗失败后管理幽门螺杆菌的指导,包括特定方案选择的最佳实践建议,并考虑影响治疗效果的患者和系统因素。本专家评论不是正式的系统评价,而是基于文献回顾提供实用建议。未对证据的强度或质量进行正式评估。因此,采用现有证据和基于共识的专家意见相结合来制定这些最佳实践建议。

相似文献

1
AGA Clinical Practice Update on the Management of Refractory Helicobacter pylori Infection: Expert Review.AGA 临床实践更新:难治性幽门螺杆菌感染的管理:专家综述。
Gastroenterology. 2021 Apr;160(5):1831-1841. doi: 10.1053/j.gastro.2020.11.059. Epub 2021 Jan 29.
2
AGA Clinical Practice Update on Integrating Potassium-Competitive Acid Blockers Into Clinical Practice: Expert Review.AGA 临床实践更新:将钾离子竞争性酸阻滞剂整合到临床实践中:专家评论。
Gastroenterology. 2024 Nov;167(6):1228-1238. doi: 10.1053/j.gastro.2024.06.038. Epub 2024 Sep 11.
3
Drugs for Helicobacter pylori infection.用于幽门螺杆菌感染的药物。
Med Lett Drugs Ther. 2017 Jul 17;59(1525):113-117.
4
How We Approach Difficult to Eradicate Helicobacter pylori.我们如何应对难以根除的幽门螺杆菌。
Gastroenterology. 2022 Jan;162(1):32-37. doi: 10.1053/j.gastro.2021.10.048. Epub 2021 Nov 3.
5
Pharmacological therapy used in the elimination of Helicobacter pylori infection: a review.用于根除幽门螺杆菌感染的药物治疗:综述
World J Gastroenterol. 2015 Jan 7;21(1):139-54. doi: 10.3748/wjg.v21.i1.139.
6
Management of Helicobacter pylori infection: The Bhubaneswar Consensus Report of the Indian Society of Gastroenterology.幽门螺杆菌感染的管理:印度胃肠病学会布巴内斯瓦尔共识报告
Indian J Gastroenterol. 2021 Aug;40(4):420-444. doi: 10.1007/s12664-021-01186-4. Epub 2021 Jul 5.
7
Fluoroquinolone-based protocols for eradication of Helicobacter pylori.基于氟喹诺酮类药物的幽门螺杆菌根除方案。
World J Gastroenterol. 2014 Jul 21;20(27):8947-56. doi: 10.3748/wjg.v20.i27.8947.
8
Efficacies of Genotypic Resistance-Guided vs Empirical Therapy for Refractory Helicobacter pylori Infection.基因耐药指导与经验性治疗对难治性幽门螺杆菌感染的疗效比较。
Gastroenterology. 2018 Oct;155(4):1109-1119. doi: 10.1053/j.gastro.2018.06.047. Epub 2018 Jun 30.
9
Treatment options for Helicobacter pylori infection when proton pump inhibitor-based triple therapy fails in clinical practice.在临床实践中,基于质子泵抑制剂的三联疗法治疗幽门螺杆菌感染失败时的治疗选择。
Aliment Pharmacol Ther. 1999 Apr;13(4):489-96. doi: 10.1046/j.1365-2036.1999.00504.x.
10
Optimizing clarithromycin-containing therapy for Helicobacter pylori in the era of antibiotic resistance.在抗生素耐药时代优化含克拉霉素的幽门螺杆菌治疗方案
World J Gastroenterol. 2014 Aug 14;20(30):10338-47. doi: 10.3748/wjg.v20.i30.10338.

引用本文的文献

1
First regional consensus on the management of infection in the Middle East.中东地区关于感染管理的首个区域共识。
World J Gastroenterol. 2025 Jul 21;31(27):107138. doi: 10.3748/wjg.v31.i27.107138.
2
2-oxoglutarate:acceptor oxidoreductase-catalyzed redox cycling effectively targets coccoid forms of Helicobacter pylori.2-氧代戊二酸:受体氧化还原酶催化的氧化还原循环有效地靶向幽门螺杆菌的球菌形态。
Nat Commun. 2025 Jul 29;16(1):6965. doi: 10.1038/s41467-025-62477-4.
3
Characteristics of gastric fluid microbiota in patients with refractory infection.

本文引用的文献

1
Clavulanic Acid in the Scope of Treatment: A Literature Review and Beyond.克拉维酸治疗范围:文献综述及其他。
Curr Rev Clin Exp Pharmacol. 2021;16(2):128-138. doi: 10.2174/1574884715666200702121417.
2
Rifabutin-Based Triple Therapy (RHB-105) for Eradication: A Double-Blind, Randomized, Controlled Trial.利福布丁三联疗法(RHB-105)根除幽门螺杆菌:一项双盲、随机、对照试验。
Ann Intern Med. 2020 Jun 16;172(12):795-802. doi: 10.7326/M19-3734. Epub 2020 May 5.
3
Application of a social media platform as a patient reminder in the treatment of Helicobacter pylori.
难治性感染患者胃液微生物群的特征
Front Microbiol. 2025 Jul 1;16:1618803. doi: 10.3389/fmicb.2025.1618803. eCollection 2025.
4
Probiotic Supplementation for Treatment of Infection: A Double-Blind Randomized Clinical Trial.补充益生菌治疗感染:一项双盲随机临床试验。
Korean J Helicobacter Up Gastrointest Res. 2023 Mar;23(1):34-41. doi: 10.7704/kjhugr.2022.0051. Epub 2023 Feb 27.
5
Targeted nanomedicines for the treatment of infection.用于治疗感染的靶向纳米药物。
Mater Today Bio. 2025 Apr 30;32:101820. doi: 10.1016/j.mtbio.2025.101820. eCollection 2025 Jun.
6
A critical review on and models for the investigation of infection.关于感染调查的[具体内容]和模型的批判性综述。 (原文中“and”前后内容缺失,翻译可能不太准确,完整准确翻译需补充完整原文信息)
Front Cell Infect Microbiol. 2025 May 14;15:1516237. doi: 10.3389/fcimb.2025.1516237. eCollection 2025.
7
Laparoscopic surgery in acute perforated gastroduodenal ulcers: an underutilized technique despite favorable short-term outcomes.腹腔镜手术治疗急性胃十二指肠溃疡穿孔:尽管短期疗效良好,但该技术未得到充分利用。
Surg Endosc. 2025 May 27. doi: 10.1007/s00464-025-11855-6.
8
Impact of an Electronic Medical Record Quality Improvement Intervention on Helicobacter pylori Treatment and Eradication Rates in a U.S. Hospital System.电子病历质量改进干预措施对美国一家医院系统中幽门螺杆菌治疗及根除率的影响
Helicobacter. 2025 Mar-Apr;30(2):e70034. doi: 10.1111/hel.70034.
9
Non-celiac Enteropathies.非乳糜泻性肠病
Curr Gastroenterol Rep. 2025 Apr 14;27(1):27. doi: 10.1007/s11894-025-00979-3.
10
A Comparative Analysis of the Clinical Application of a Novel Serum Antibody Typing Test and the C-Urea Breath Test.新型血清抗体分型检测与C-尿素呼气试验临床应用的对比分析
Diagnostics (Basel). 2025 Apr 5;15(7):934. doi: 10.3390/diagnostics15070934.
社交媒体平台作为幽门螺杆菌治疗中患者提醒的应用。
Helicobacter. 2020 Apr;25(2):e12682. doi: 10.1111/hel.12682. Epub 2020 Feb 23.
4
Review of current diagnostic methods and advances in diagnostics in the era of next generation sequencing.当前诊断方法综述及下一代测序时代诊断学的进展。
World J Gastroenterol. 2019 Aug 28;25(32):4629-4660. doi: 10.3748/wjg.v25.i32.4629.
5
Helicobacter pylori eradication rates with concomitant and tailored therapy based on 23S rRNA point mutation: A multicenter randomized controlled trial.基于 23S rRNA 点突变的伴随和定制治疗的幽门螺杆菌根除率:一项多中心随机对照试验。
Helicobacter. 2019 Oct;24(5):e12654. doi: 10.1111/hel.12654. Epub 2019 Aug 14.
6
Atorvastatin in combination with conventional antimicrobial treatment of Helicobacter pylori eradication: A randomized controlled clinical trial.阿托伐他汀联合常规抗菌药物治疗幽门螺杆菌根除:一项随机对照临床试验。
J Gastroenterol Hepatol. 2020 Jan;35(1):71-75. doi: 10.1111/jgh.14810. Epub 2019 Aug 16.
7
Effect of Previous Nitroimidazole Treatment on Helicobacter pylori Eradication Success.先前使用硝基咪唑治疗对幽门螺杆菌根除成功率的影响。
J Clin Gastroenterol. 2020 Apr;54(4):333-337. doi: 10.1097/MCG.0000000000001237.
8
Simvastatin improves the eradication rate of : upper Egypt experience.辛伐他汀提高根除率:上埃及地区的经验
Infect Drug Resist. 2019 Jun 5;12:1529-1534. doi: 10.2147/IDR.S202346. eCollection 2019.
9
Impact of Previous Exposure to Macrolide Antibiotics on Helicobacter pylori Infection Treatment Outcomes.大环内酯类抗生素既往暴露对幽门螺杆菌感染治疗结局的影响。
Am J Gastroenterol. 2019 Jun;114(6):900-906. doi: 10.14309/ajg.0000000000000223.
10
Twice daily short-message-based re-education could improve Helicobacter pylori eradication rate in young population: A prospective randomized controlled study.基于每日两次短信的再教育可提高青年人群的幽门螺杆菌根除率:一项前瞻性随机对照研究。
Helicobacter. 2019 Jun;24(3):e12569. doi: 10.1111/hel.12569. Epub 2019 Mar 8.